Purdue Pharma used deceptive sales tactic for OxyContin after settlement, ex-sales rep says

Purdue Pharma laid off its entire sales team this week. Now only on “CBS This Morning,” a former Purdue sales representative reveals the drugmaker downplayed the dangers of opioids, even after pleading guilty to a felony charge of “misbranding.” Purdue’s 2007 settlement with the Justice Department included more than $630 million in fines. Tony Dokoupil spoke with the whistleblower.

Categories: Health

Leave a Reply

Your email address will not be published. Required fields are marked *